With all this mounting excitement,it may be prudent to be circumspect here.The wiseowl report suggested that 2014 would be the first good year for KSX,correctly pointing out that bio-tech investors usually wait for a couple of years of strong sales performance.And the 4 cent projection won't excite too many LT holders-most bought when above 4 cents! Theories abound:options expiry,sophisticated investor profit-taking,placement effects etc.Nobody really knows.One thing is certain:no-one is rushing to buy 'bargain-basement' shares.This has to be highly significant:consider the underwhelming response to ALL announcements over the last year.The market is not ready to embrace KSX yet. If you want to know when,go to a fortune-teller.Most here are prepared to wait out this long and painful process because this technology is unique and it will have it's day.
Good Luck All
KSX Price at posting:
1.9¢ Sentiment: LT Buy Disclosure: Held
